Cargando…
Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
RATIONALE & OBJECTIVE: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline uses risk stratification to guide the decision to initiate nonstatin lipid-lowering medication among adults with atherosclerotic cardiovascular disease (CVD). We determined a...
Autores principales: | Poudel, Bharat, Rosenson, Robert S., Bittner, Vera, Gutiérrez, Orlando M., Anderson, Amanda H., Woodward, Mark, Deo, Rajat, Carson, April P., Mues, Katherine E., Dluzniewski, Paul J., Jaar, Bernard G., Lora, Claudia M., Taliercio, Jonathan, Muntner, Paul, Colantonio, Lisandro D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515092/ https://www.ncbi.nlm.nih.gov/pubmed/34693254 http://dx.doi.org/10.1016/j.xkme.2021.04.008 |
Ejemplares similares
-
Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2023) -
Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
por: Wang, Ke, et al.
Publicado: (2020) -
Prediction of Incident Heart Failure in CKD: The CRIC Study
por: Zelnick, Leila R., et al.
Publicado: (2022) -
Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era
por: Rosenson, Robert S., et al.
Publicado: (2019) -
Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline
por: Alanaeme, Chibuike J., et al.
Publicado: (2022)